Phase II Study of Carboplatin Combined with Biweekly Docetaxel for Advanced Non-small Cell Lung CancerOsamu Ishimoto, Toshihiro Nukiwa, Shunichi Sugawara et al.|Journal of Thoracic Oncology|2006Cited by 6
Establishment of an etoposide (VP-16)-resistant subline of THP-1 human monocytic leukemia cell line.Yasuo Saijo, Masakichi Motomiya, Nobuko Kumano et al.|The Tohoku Journal of Experimental Medicine|1989Cited by 5
Phase II Study of Carboplatin Combined with Biweekly Docetaxel for Advanced Non-small Cell Lung CancerOsamu Ishimoto, Toshihiro Nukiwa, Hiroshi Miki et al.|Journal of Thoracic Oncology|2006Cited by 5
Chemotherapy versus chemo-BRM therapy in adenocarcinoma of the lung: In relation to quality of lifeYasutomo Nakai, Masao Ôta, Kôichi Kimura et al.|Lung Cancer|1991Cited by 0